Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 33, 2011 - Issue 9
57
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Neuroprotective effects of mesenchymal stem cell transplantation in animal model of cerebellar degeneration

, , , &
Pages 913-920 | Published online: 19 Jul 2013

References

  • Voogd J, Glickstein M. The anatomy of the cerebellum. Trends Cogn Sci 1998; 2: 307–13.
  • Margolis RL. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2002; 2: 447–56.
  • Riva D, Giorgi C. The cerebellum contributes to higher function during development: evidence from a series of children treated for posterior fossa tumors. Brain 2000; 123: 1051–61.
  • Schmahmann JD, Pandya DN. Anatomical investigation of projections to the basis points from posterior parietal associa-tion cortices in rhesus monkey. J Comp Neurol 1998; 289: 53–73.
  • Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuro-psychological consequences of cerebellar tumor resection in children: cerebellar cognitive affective syndrome in a pediatric population. Brain 2000; 123: 1041–50.
  • Kelly RM, Strick PL. Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. J Neurosci 2003; 23: 8432–44.
  • Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development and evaluation of a brief ataxia rating scale (BARS) from a modified form of the ICARS. Mov Disord 2009; 24: 1820–8.
  • Schmahmann JD, MacMore J, Vangel M. Cerebellar stroke without motor deficits: Clinical evidence for motor and non-motor domains within the human cerebellum. Neuroscience 2009; 162: 852–61.
  • Altman J, Bayer SA. Development of the cerebellar system. In relation to its evolution, structure and function. New York: CRC Press; 1997.
  • Kerry DM, Dwivedi PP, Hahn CN, Morris HA, Omdahl JL, May BK. Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 1996; 271: 29715-21.
  • Schmahmann JD. Disorders of the cerebellum: ataxia, dysme-tria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367–78.
  • Armstrong RJ, Svendsen CN. Neural stem cells: from cell biology to cell replacement. Cell Transplant 2000; 9: 139–152.
  • Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp 2000; 231: 7–15.
  • Freeman TB, Hauser RA, Sanberg PR, Saporta S. Neural transplantation for the treatment of Huntington's disease. Prog Brain Res 2000; 127: 405–11.
  • Svendsen CN, Caldwell MA. Neural stem cells in the developing central nervous system: implications for cell therapy through transplantation. Prog Brain Res 2000; 127: 13–34.
  • Carletti B, Grimaldi P, Magrassi L, Rossi F. Specification of cerebellar progenitors after heterotopic-heterochronic trans-plantation to the embryonic CNS in vivo and in vitro. J Neurosci 2002; 22: 7132–46.
  • Cendelin J, Korelusova I, Vozeh F. Comparison of embryonic cerebellar graft survival in adult Lurcher mutant mice of strains C3H and C57B1/7. Prague Med Rep 2006; 107: 89–94.
  • Ourednik J, Ourednik V. Graft-induced plasticity in the mammalian host CNS. Cell Transplant 2004; 13: 307–18.
  • Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M. Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res 2010; 32: 166–72.
  • Baksh D, Davies EJ, Zandstra WP. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 2003; 31: 723–32.
  • Black BI, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cell Mol Dis 2001; 27: 632–6.
  • Kuhn HG, Palmer TD, Fuchs E. Adult neurogenesis: a compensatory mechanism for neural damage. Eur Arch Psychiatry Clin Nerosci 2001; 251: 152–8.
  • Steindler DA, Pincus DW. Stem cells and neuropoiesis in the adult human brain. Lancet 2002; 359: 1047–54.
  • Popovica N, Maingayb M, Kirikb D, Brundin P. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes. Exp Neurol 2005; 193: 65–74.
  • Harting MT, Jimenez F, Adams SD. Acute, regional inflam-matory response after traumatic brain injury: implications for cellular therapy. J Surg Res 2008; 144: 425.
  • Alaei H, Borjeian L, Azizi M, Orian S, Pourshanazari A, Hanninen O. Treadmill running reverses retention deficit induced by morphine. Eur J Pharmacol 2006; 536: 138–41.
  • Lu HX, Levis H, Melhem N, Parker T. Toxin-produced Purkinje cell death: a model for neural stem cell transplantation studies. Brain Res 2008; 1207: 207–13.
  • Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000; 61: 364–70.
  • Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226: 507–20.
  • Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568–84.
  • Jeong SW, Chu K, Jung KH, Kim SU, Kim M, Roh JK. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003; 24: 2258–63.
  • Lescaudron L, Unni D, Dunbar LG. Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: behavioral and morphological outcomes. J Neurosci 2003; 113: 945–56.
  • Emborg ME. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J Neurosci Methods 2004; 139: 121–43.
  • Park HJ, Lee PH, Bang OY, Lee G, Ahn YH. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008; 107: 141–51.
  • Karussis D, Kassis I, Kurkalli BG, Slavin S. Immuno-modulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases. J Neurol Sci 2008; 265: 131–5.
  • Häusser M, Roth A. Dendritic and somatic glutamate receptor channels in rat cerebellar Purkinje cells. J Physiol 1997; 501: 77–95.
  • Rosenmund C, Legendre P, Westbrook GL. Expression of NMDA channels on cerebellar Purkinje cells acutely dis-sociated from newborn rats. J Neurophysiol 1992; 68: 1901–5.
  • Hamann M, Rossi DJ, Mohr C, Andrade AL, Attwell D. The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain 2005; 128: 2408–20.
  • O'Heam E, Molliver ME. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine. Neuroscience 2004; 127: 373–83.
  • Allen G, Courchesne E. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry 2003; 160: 262–73.
  • Wallesch CW, Horn A. Long-term effects of cerebellar pathology on cognitive functions. Brain Cogn 1990; 14: 19–25.
  • Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science 1994; 266: 458–51.
  • Volkow ND. Low cerebellar metabolism in medicated patients with chronic schizophrenia Am J Psych 1992; 149: 686–8.
  • Heath RG, Franklin DE, Shraberg D. Gross pathology of the cerebellum in patients diagnosed and treated as functional psychiatric disorders. J Nerv Ment Dis 1979;167;585–92.
  • Desmond JE, Gabrieli JD, Wagner AD, Ginier BL, Glover GH. Lobular patterns of cerebellar activation in verbal work-ing-memory and finger-tapping tasks as revealed by functional MRI. J Neurosci 1997; 17: 9675–85.
  • Neau JP, Arroyo-Anllo E, Bonnaud V, Ingrand P, Gil R. Neuropsychological disturbances in cerebellar infarcts. Acta Neurol Scand 2000; 102: 363–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.